210 related articles for article (PubMed ID: 32398330)
21. Retraction of Studies on Potential Drug Therapies for COVID-19: A Call for Reliability and Scientific Integrity.
Guzman-Prado Y
Am J Cardiol; 2020 Oct; 132():173. PubMed ID: 32713654
[No Abstract] [Full Text] [Related]
22. Pre- and post-treatment chest CT changes in a patient with COVID-19.
Fu B; Qian K; Fu X
Med Clin (Barc); 2020 Jul; 155(1):49. PubMed ID: 32417029
[No Abstract] [Full Text] [Related]
23. Kidney Transplantation and COVID-19.
Merhi B; Gohh R
R I Med J (2013); 2020 Sep; 103(8):34-37. PubMed ID: 32900010
[No Abstract] [Full Text] [Related]
24. Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series.
Fu D; Cao R; Zhao L; Li W; Zhong W; Wen J
Crit Care; 2020 Sep; 24(1):578. PubMed ID: 32977854
[No Abstract] [Full Text] [Related]
25. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(698):1272-1273. PubMed ID: 32558461
[No Abstract] [Full Text] [Related]
26. Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.
Polansky H; Lori G
J Evid Based Integr Med; 2020; 25():2515690X20932523. PubMed ID: 32551855
[TBL] [Abstract][Full Text] [Related]
27. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
Madhusoodanan J
Proc Natl Acad Sci U S A; 2020 May; 117(20):10616-10620. PubMed ID: 32350142
[No Abstract] [Full Text] [Related]
28. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(697):1218-1219. PubMed ID: 32520464
[No Abstract] [Full Text] [Related]
29. Audio Interview: New Data on Remdesivir in Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
[No Abstract] [Full Text] [Related]
30. Optimising effectiveness of health care and value of clinical trials in the COVID -19 outbreak.
Filippis G
Pharmacol Res; 2020 Aug; 158():104993. PubMed ID: 32502640
[No Abstract] [Full Text] [Related]
31. How to Discover Antiviral Drugs Quickly.
Parks JM; Smith JC
N Engl J Med; 2020 Jun; 382(23):2261-2264. PubMed ID: 32433861
[No Abstract] [Full Text] [Related]
32. [Chloroquine as a possible treatment for COVID-19].
Coumou J; de Vries PJ
Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391999
[TBL] [Abstract][Full Text] [Related]
33. Favipiravir, an antiviral for COVID-19?
Coomes EA; Haghbayan H
J Antimicrob Chemother; 2020 Jul; 75(7):2013-2014. PubMed ID: 32417899
[No Abstract] [Full Text] [Related]
34. The coronavirus outbreak could make it quicker and easier to trial drugs.
Ledford H
Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
[No Abstract] [Full Text] [Related]
35. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
36. Lessons from the Italian COVID-19 frontline.
Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
[No Abstract] [Full Text] [Related]
37. Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza.
Anderson PO
Breastfeed Med; 2020 Mar; 15(3):128. PubMed ID: 32129667
[No Abstract] [Full Text] [Related]
38. [Impact of drugs used for the treatment of 2019 novel coronavirus on cardiovascular system].
Xie SY; Deng W; Tang QZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):546-551. PubMed ID: 32347088
[TBL] [Abstract][Full Text] [Related]
39. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
40. The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics.
Siccardi M; Schapiro J; Di Perri G; Back DJ
J Antimicrob Chemother; 2020 Sep; 75(9):2381-2383. PubMed ID: 32591771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
